Taiwan FDA registration 75d84a5394b1364df7f3d72b3f267404

Berecoron undifferentiated heparin correction solution

TW: 倍瑞可隆未分化肝素校正液

Taiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH·Registered Jul 03, 2012 – Jul 03, 2022Cancelled

Registration details

Analysis ID: 75d84a5394b1364df7f3d72b3f267404
Customs Code: DHA00602367108

Company information

Manufacturer: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer Country: Germany
Authorized Representative: SYSMEX TAIWAN CO., LTD.

Product details

Intended Use: This product is used as a correction solution for the detection of undifferentiated heparin with the Belikolon heparin reagent.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.5425 Versatile system for in vitro agglutination studies
Import Information: import

Dates and status

Registration Date: Jul 03, 2012
Expiry Date: Jul 03, 2022
Cancellation Date: Apr 12, 2024

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for Berecoron undifferentiated heparin correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 75d84a5394b1364df7f3d72b3f267404 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.